Literature DB >> 6970629

Deoxycoformycin toxicity in mice after long-term treatment.

R P Agarwal.   

Abstract

Deoxycoformycin, a tight-binding inhibitor of the enzyme adenosine deaminase, is a potent lymphocytotoxic agent. To examine the effect of deoxycoformycin on mouse tissues the drug was administered IP either by single or by repeated injections at one of two dose levels (0.2 or 10.0 mg/kg). Treatment with repeated injections at the higher dose caused retardation of growth and increases in lung and splenic mass. Body temperature, hematocrit, and total leukocyte count remained constant. Single injections at the lower dose caused complete inhibition of adenosine deaminase in liver and blood, and partial inhibition in jejunum and spleen, but at the higher dose complete inhibition of the enzyme in all tissues was obtained. Dosage appeared to have no effect on the rate of recovery of the deoxycoformycin-inhibited enzyme but marked tissue differences were observed. The enzymic activity recovered rapidly in jejunum (100% in 1 day) but slowly in other tissues (after 28 days, about 60% in spleen and liver; about 85% in kidney and blood, and 100% in lungs). These observations suggest that the recovery of inhibited enzyme depends largely upon the rate of proliferation of cells and protein synthesis. These tissue differences in recovery rates may play a role in the pharmacological and chemotherapeutic behavior of this drug.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6970629     DOI: 10.1007/BF00435409

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  7 in total

1.  Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.

Authors:  G A LePage; L S Worth; A P Kimball
Journal:  Cancer Res       Date:  1976-04       Impact factor: 12.701

2.  Tight binding inhibitors--VI. Interactions of deoxycoformycin and adenosine deaminase in intact human erythrocytes and sarcoma 180 cells.

Authors:  T Rogler-Brown; R P Agarwal; R E Parks
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

3.  Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors.

Authors:  R P Agarwal; T Spector; R E Parks
Journal:  Biochem Pharmacol       Date:  1977-03-01       Impact factor: 5.858

4.  In vivo toxicity to lymphoid tissue by 2'-deoxycoformycin.

Authors:  J F Smyth; R C Young; D M Young
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

5.  In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.

Authors:  R P Agarwal
Journal:  Biochem Pharmacol       Date:  1980-02       Impact factor: 5.858

6.  Studies on the effects of infusion of enzyme inhibitors on mouse adenosine deaminase.

Authors:  P P Trotta; M P Ahland; G F Brown; M E Balis
Journal:  Mol Pharmacol       Date:  1978-01       Impact factor: 4.436

7.  Recovery of 2'-deoxycoformycin-inhibited adenosine deaminase of mouse erythrocytes and leukemia L1210 in vivo.

Authors:  R P Agarwal
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.